WallStreetZenWallStreetZen

NASDAQ: INCY
Incyte Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

INCY past earnings growth

How has INCY's earnings growth performed historically?
Company
-52.27%
Industry
16.33%
Market
40.59%
INCY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INCY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

INCY past revenue growth

How has INCY's revenue growth performed historically?
Company
8.35%
Industry
112.01%
Market
13.97%
INCY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INCY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INCY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INCY earnings and revenue history

Current Revenue
$3.6B
Current Earnings
$425.0M
Current Profit Margin
11.8%

INCY Return on Equity

Current Company
9.2%
Current Industry
15.6%
Current Market
-9.5%
INCY's Return on Equity (9.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INCY announces earnings.

INCY Return on Assets

Current Company
7%
Current Industry
2.2%
INCY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INCY Return on Capital Employed

Current Company
12.28%
Current Industry
17.7%
INCY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INCY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INCY$3.61B$725.40M$424.98M+14.96%-0.13%
UTHR$2.20B$1.27B$899.80M+5.20%+8.88%
LEGNN/AN/AN/AN/AN/A
TECH$1.14B$404.85M$246.70M+11.58%+12.91%
SRPT$1.10B-$604.01M-$690.88M+32.18%N/A
View Top Biotech Stocks

INCY earnings dates

Next earnings date
Feb 5, 2024

Incyte Earnings & Revenue FAQ

What were INCY's earnings last quarter?

On Invalid Date, Incyte (NASDAQ: INCY) reported Q3 2023 earnings per share (EPS) of $0.76, up 49.02% year over year. Total Incyte earnings for the quarter were $171.27 million. In the same quarter last year, Incyte's earnings per share (EPS) was $0.51.

If you're new to stock investing, here's how to buy Incyte stock.

What was INCY's earnings growth in the past year?

As of Q4 2023, Incyte's earnings has grown -52.27% year over year. This is 68.6 percentage points lower than the US Biotechnology industry earnings growth rate of 16.33%. Incyte's earnings in the past year totalled $424.98 million.

What is INCY's earnings date?

Incyte's earnings date is Invalid Date. Add INCY to your watchlist to be reminded of INCY's next earnings announcement.

What was INCY's revenue last quarter?

On Invalid Date, Incyte (NASDAQ: INCY) reported Q3 2023 revenue of $919.03 million up 11.63% year over year. In the same quarter last year, Incyte's revenue was $823.30 million.

What was INCY's revenue growth in the past year?

As of Q4 2023, Incyte's revenue has grown 8.35% year over year. This is 103.65 percentage points lower than the US Biotechnology industry revenue growth rate of 112.01%. Incyte's revenue in the past year totalled $3.61 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.